• 2020

  Establishment of ARUDA Co., Ltd. (23rd Oct. 2020)

  

• 2021

  Investment Attraction from Boryung Holdings

  Launching of SAVE HA Filler

  Chinese Market Entry

  

• 2022

  Establishment of Corporate Affiliated Research Institute

  Launching of A-Series Products

  Expansion of Facilities for Manufacturing, R&D

  

Focusing on hyaluronic acid-based filler formulations and extracellular matrix composite formulations,
we are securing a number of first-in-class pipelines in addition to Best-in-Class products.